Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2016

Total Assets: $21.0M

Liabilities Breakdown FY2016

Total Liabilities: $4.0M